We and others have shown that the HFD/STZ model appears to produce a degree of neurodegeneration and mimics pre-AD symptoms in the hippocampus, including memory loss, insulin resistance, Aβ aggregation, and tau hyperphosphorylation. The gene discussed is MAPT; the disease is Alzheimer disease.